efficacy

You have access
Pooled-analysis of Lipegfilgrastim Effectiveness and Safety Among Patients With Blood Malignancies in the Real-world Setting
RUTH PETTENGELL, THOMAS WOLFF, THOMAS GOEHLER and NICOLA CASCAVILLA

Anticancer Research January 2021, 41 (1) 347-354; DOI: https://doi.org/10.21873/anticanres.14782
You have access
Oral Recombinant Methioninase Sensitizes a Bladder Cancer Orthotopic Xenograft Mouse Model to Low-dose Cisplatinum and Prevents Metastasis
YU SUN, HIROTO NISHINO, NORIHIKO SUGISAWA, JUN YAMAMOTO, KAZUYUKI HAMADA, GUANGWEI ZHU, HYE IN LIM and ROBERT M. HOFFMAN

Anticancer Research November 2020, 40 (11) 6083-6091; DOI: https://doi.org/10.21873/anticanres.14629
You have access
ABL1-Directed Inhibitors for CML: Efficacy, Resistance and Future Perspectives
MICHELE MASSIMINO, STEFANIA STELLA, ELENA TIRRÒ, MARIA STELLA PENNISI, SILVIA RITA VITALE, ADRIANA PUMA, CHIARA ROMANO, SANDRA DI GREGORIO, CRISTINA TOMARCHIO, FRANCESCO DI RAIMONDO and LIVIA MANZELLA

Anticancer Research May 2020, 40 (5) 2457-2465; DOI: https://doi.org/10.21873/anticanres.14215
You have access
Immune-related Adverse Effects and Outcome of Patients With Cancer Treated With Immune Checkpoint Inhibitors
ONDREJ FIALA, ONDREJ SOREJS, JAN SUSTR, RADEK KUCERA, ONDREJ TOPOLCAN and JINDRICH FINEK

Anticancer Research March 2020, 40 (3) 1219-1227; DOI: https://doi.org/10.21873/anticanres.14063
You have access
Prospective Feasibility Study of Amrubicin and Bevacizumab Therapy for Patients With Previously Treated Advanced NSCLC
HISAO IMAI, KYOICHI KAIRA, ICHIRO NARUSE, NORIMITSU KASAHARA, YOSUKE KAMIDE, AKIHIRO ONO, TOMOMI MASUDA, NORIAKI SUNAGA, KOICHI MINATO and TAKESHI HISADA

Anticancer Research March 2020, 40 (3) 1571-1578; DOI: https://doi.org/10.21873/anticanres.14104
You have access
Impact of Primary Tumor Localization on the Efficacy of Bevacizumab in Metastatic Colorectal Cancer
FRANK JORDAN, NINA GRUNDMANN, GERHARD SCHENKIRSCH, BRUNO MÄRKL, HELMUTH MESSMANN, MATTHIAS ANTHUBER, CHRISTOPH SCHMID and MARTIN TREPEL

Anticancer Research September 2018, 38 (9) 5539-5546; DOI: https://doi.org/10.21873/anticanres.12889
You have access
Significance of Age in Japanese Patients Receiving Sunitinib as First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: Comparative Assessment of Efficacy and Safety between Patients Aged <75 and ≥75 Years
HIDEAKI MIYAKE, RYOTA AKI, YUTO MATSUSHITA, KEITA TAMURA, DAISUKE MOTOYAMA, TOSHIKI ITO, TAKAYUKI SUGIYAMA and ATSUSHI OTSUKA

Anticancer Research June 2018, 38 (6) 3593-3599; DOI: https://doi.org/10.21873/anticanres.12633
You have access
Efficacy and Safety of Neoadjuvant Chemoradiotherapy Following Esophagectomy with Japanese-style Extended 3-Field Lymphadenectomy for Thoracic Esophageal Cancer
SATORU MOTOYAMA, YUSUKE SATO, TOMOHIKO SASAKI, AKIYUKI WAKITA, YUTA KAWAKITA, JIAJIA LIU, YUSHI NAGAKI, HAJIME SAITO, KAZUHIRO IMAI, HAYATO KONNO, KAORI T. MIZUSAWA and YOSHIHIRO MINAMIYA

Anticancer Research October 2017, 37 (10) 5837-5843;
You have access
Effective Metabolic Targeting of Human Osteosarcoma Cells In Vitro and in Orthotopic Nude-mouse Models with Recombinant Methioninase
KENTARO IGARASHI, KEI KAWAGUCHI, TASUKU KIYUNA, KENTARO MIYAKE, TAKASHI MURAKAMI, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, HIROYUKI TSUCHIYA and ROBERT M. HOFFMAN

Anticancer Research September 2017, 37 (9) 4807-4812;
You have access
Anti-metastatic Efficacy of Traditional Chinese Medicine (TCM) Ginsenoside Conjugated to a VEFGR-3 Antibody on Human Gastric Cancer in an Orthotopic Mouse Model
XIAOJUN DAI, DONGMEI LIU, MOXIANG LIU, XIAOCHUN ZHANG, WEIMING WANG, FENG JIN, YAYUN QIAN, XUANYI WANG, JINGJING ZHAO, YONGJIAN WU, FANGFANG XIONG, NA CHANG, YU SUN, ZHIJIAN YANG, ROBERT M. HOFFMAN and YANQING LIU

Anticancer Research March 2017, 37 (3) 979-986;

Main menu

User menu

Search

efficacy

Pages